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Abstract
Background: Intermittent preventive treatment of malaria in children (IPTc) involves the administration of a course of anti-
malarial drugs at specified time intervals to children at risk of malaria regardless of whether or not they are known to be
infected. IPTc provides a high level of protection against uncomplicated and severe malaria, with monthly sulphadoxine-
pyrimethamine plus amodiaquine (SP&AQ) and sulphadoxine-pyrimethamine plus piperaquine being the most efficacious
regimens. A key challenge is the identification of a cost-effective delivery strategy.
Methods: A community randomized trial was undertaken in Jasikan district, Ghana to assess IPTc effectiveness and costs
using SP&AQ delivered in three different ways. Twelve villages were randomly selected to receive IPTc from village health
workers (VHWs) or facility-based nurses working at health centres’ outpatient departments (OPD) or EPI outreach clinics.
Children aged 3 to 59 months-old received one IPT course (three doses) in May, June, September and October. Effectiveness
was measured in terms of children covered and adherent to a course and delivery costs were calculated in financial and
economic terms using an ingredient approach from the provider perspective.
Results: The economic cost per child receiving at least the first dose of all 4 courses was US$4.58 when IPTc was delivered
by VHWs, US$4.93 by OPD nurses and US$ 5.65 by EPI nurses. The unit economic cost of receiving all 3 doses of all 4 courses
was US$7.56 and US$8.51 when IPTc was delivered by VHWs or facility-based nurses respectively. The main cost driver for
the VHW delivery was supervision, reflecting resources used for travelling to more remote communities rather than more
intense supervision, and for OPD and EPI delivery, it was the opportunity cost of the time spent by nurses in dispensing IPTc.
Conclusions: VHWs achieve higher IPTc coverage and adherence at lower costs than facility-based nurses in Jasikan district,
Ghana.
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Introduction
Intermittent preventive treatment of malaria is the administra-
tion of a full course of an anti-malarial treatment to a population
at risk at specified time points, regardless of whether or not they
are known to be infected. The World Health Organization
recommends IPT for the prevention of malaria in pregnant
women (IPTp) [1] and infants (IPTi) [2] and the potential role of
IPT as a malaria control strategy in children in areas of seasonal
transmission risk is gaining increasing interest. A recent systematic
literature review was conducted to assess the safety and efficacy of
IPTc administered to children under five years of age in countries
of the Sahel and sub-Sahel where malaria transmission is highly
seasonal. Twelve studies were identified and a pooled analysis
indicated that IPTc administered monthly offered a protective
efficacy of 82% against clinical attacks and suggested an impact on
all-cause mortality [3]. Different drug combinations were used in
different settings with monthly sulphadoxine-pyrimethamine (SP)
plus amodiaquine (AQ) and SP plus piperaquine being the most
efficacious regimens. IPTc was safe with no serious drug related
adverse events [3].
A key challenge for IPT is the identification of an appropriate
delivery strategy. IPT is dispensed to pregnant women during
their regular visits to antenatal clinics and to infants at routine
EPI (Expanded Programme on Immunisation) visits. However, it
is not clear how to reach children under five years of age who do
not make regular contacts with routine health care services.
Different delivery strategies have therefore been explored in
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workers (VHWs) in Senegal and Ghana [4,5], supplemented in
the latter by health facility-based staff (including nurses working
at outpatient departments (OPD) and nurses running EPI
outreach clinics (EPI)) [5], or as in The Gambia, by mobile
reproductive and child health trekking (RCH) teams [6]. When
community and facility-based delivery strategies were compared,
higher coverage rates were achieved when IPTc was dispensed
by VHWs compared to nurses. During a randomised trial of
IPTc using SP+AQ given over 3 months in The Gambia, 74% of
children who received IPT from VHWs received at least the first
dose of the 3 courses compared to 48% of children who received
treatment from the RCH teams [6]. In another randomized trial
of IPTc using SP+AQ given over 4 months in Ghana, 91% of
children in the VHW arm of the trial received the first dose of at
least 3 courses compared with 87% of children in the OPD+EPI
arm [5]. From a policy maker’s perspective, the choice of which
delivery strategies to use for IPTc must take into account the
resources required for implementing IPT through the different
delivery options and the potential savings of using a particular
strategy or combination of strategies. However, to date, there is
limited evidence on which to base such a decision, with a single
comparative cost analysis conducted during the Gambian study,
which showed that IPTc was less costly when dispensed by
VHWs than by RCH teams, at US$ 1.63 and US$ 3.47 per child
covered respectively [6]. The study presented in this paper
provides new information on the costs of delivering IPTc
through different routes by drawing on the findings of a
community randomised trial conducted in Ghana, during which
IPTc was dispensed to children by OPD or EPI nurses or by
VHWs [5].
Methods
Ethics Statement
The study was approved by the ethics committees of the
London School of Hygiene and Tropical Medicine and of the
Ghana Health Service/Ministry of Health.
Study population
Both the community randomised trial and the costing study
were carried out in Jasikan district, Volta region, Ghana. A
detailed description of the district is given elsewhere [5]. Briefly, in
2004, the district population was estimated at 122,265 inhabitants,
with most residents being subsistence farmers cultivating primarily
rice and maize. The population was served by 2 hospitals, 9 health
centres, 17 reproductive and child health clinics, 3 private
maternity homes, 2 private clinics and an additional 80 outreach
clinics providing EPI services. EPI coverage was high in the
district, with around 80% of children aged one year and above
fully vaccinated. In Ghana, malaria transmission is seasonal and
occurs during the rainy season (April to November), with peaks
from May to June and September to October. At the time of the
study, insecticide treated nets (ITNs) were subsidized at public
health centres and EPI outreach clinics, and vouchers to be used in
private shops were available at antenatal clinics. However, only
one third of households reported that they owned at least one bed
net, of which 9.5% were ITNs. In Jasikan, children experienced
between 3 to 6 clinical attacks annually, with severe malaria being
the most common cause of hospital admission and death in
children under five years of age. In 2006, artesunate and
amodiaquine combination therapy became the recommended
first line treatment for uncomplicated Plasmodium falciparum malaria
in Ghana.
Study design
The community randomized trial was designed to assess the
effectiveness of IPTc in terms of coverage and adherence achieved
through OPD, EPI and VHW delivery. Informed written consent
was obtained from all the care takers of the eligible children before
enrolment in the study.
The design of the trial has been reported in details elsewhere,
including sample size calculations and sampling procedures [5].
Twelve villages were randomly selected to receive IPTc through
OPD (3 villages), EPI outreach clinics (3 villages) or VHWs (6
villages). SP+AQ were dispensed to parents/care-takers of
children aged 3–59 month-old in May, June, September and
October 2006. Nine hundred and sixty-four children were
enrolled, of whom 248 were in the OPD arm, 244 in the EPI
arm and 472 in the VHW arm.
Children in each arm of the trial were similar in regard to age,
gender, anthropometric indices, malaria parasite prevalence,
household insecticide treated net ownership and whether they
slept under a net the night before enrolment. Before the start of the
IPTc intervention, nurses and VHWs received one day of training
on how to identify drugs packed for each child, administer drugs
and refer children to public health facilities.
At the beginning of May, June, September and October, IPTc
drugs were delivered to health facilities and VHWs by the district
health management team (DHMT) staff who participated in the
trial. OPD nurses dispensed IPT to the study children during their
facility’s normal opening hours on two scheduled consecutive days
and EPI nurses delivered IPTc during the course of their routine
activities at one-day monthly outreach clinics. VHWs dispensed
IPTc during three consecutive scheduled days from a central point
of each village. Nurses and VHWs administered the first IPT dose,
with tablets being crushed and mixed with sweetened water, whilst
the two subsequent doses were administered at home by parents/
care takers [5]. Drugs not distributed during the scheduled IPTc
days were collected from dispensers a few days later by the same
DHMT team that delivered the drug supplies. Visits to supervise
nurses and VHWs during the administration of the first IPT dose
and to monitor children’s adherence to the second and third doses
- five days after the administration of the first dose - were also
conducted by DHMT team members.
Coverage and adherence outcomes
IPTc effectiveness was measured for each delivery strategy
(VHWs, OPD, EPI) and for the combined two strategies that used
the routine public health system (OPD and EPI). Effectiveness was
defined in terms of the number of children scheduled to receive
IPTc who received treatment (coverage) and the number of doses
taken by the covered children (adherence). Children were
considered ‘‘fully’’ covered if they received the first supervised dose
of all 4 courses, and ‘‘acceptably’’ covered if they received the first
supervised dose of at least 3 courses. Coverage rates were calculated
for IPTc delivered through each delivery strategy (Table 1).
Adherence rates were measured by DHMT supervisors who visited
a different sub-sample of children each month, with all children
visited once during the study, and who asked parents/ care-takers
about any IPT drugs left and whether the child had been sick [5].
The adherence rate was calculated by multiplying the proportion of
children enrolled who were covered at that particular month by the
proportion of children visited each month who took all three doses
(Table 2). The proportion of children enrolled who took all three
doses of four courses (defined as the proportion of children ‘‘fully
covered and fully adherent’’) was obtained by multiplying the
proportions of children covered who took all three doses in May,
June,Septemberand October.The proportionofchildrenwhotook
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proportion of children ‘‘acceptably covered and fully adherent’’)
was obtained by multiplying the proportions of children covered
who took all three doses in at least three of the four months during
which IPTc was dispensed. Adherence rates were calculated for
children covered through the VHW delivery strategy or the facility-
based strategy (OPD and EPI) (Table 2).
Costing
Total unit financial and economic costs of IPTc delivered
through the three different strategies were calculated from the
perspective of the provider only. Household costs associated with
accessing IPTc were not collected during this study. Cost data
were collected following an ingredient approach [7] using records
and activity data supplied by the DHMT. Care was taken to
exclude resources related to research activities (e.g. costs of
collecting the IPTc drugs that had not been dispensed at the end of
each of the trial months). Resources were categorised under IPTc
drug costs, training costs, delivery to distribution point costs,
distribution to parents/care-takers costs, supervision costs and
communications costs. Financial costs were actual expenditures
incurred by the DHMT, including IPTc drugs, training allow-
ances, personnel incentives, transport and supplies.
Drug costs were derived from the MSH drug indicator guide
using the median buyer price for 2006 [8]. In order to account for
drug wastage, the cost of a full tablet was calculated across all age
groups, although some children had received half a tablet
according to the age dependent dosage regimen. One monthly
IPTc course was valued at US$0.05, with l tablet of SP at US$0.02
and a 3-day regimen of AQ at US$0.03.
During the one-day training course, VHWs, nurses and
supervisors each received an attendance fee of US$5.00 supple-
mented by an allowance of around US$3.50 for refreshments and
lunch.
During the four-month implementation period, a monthly
incentive of US$10.00 was given to each VHW and nurse involved
in IPTc distribution. The US$10.00 amount was set on the basis of
incentives paid to VHWs and nurses involved in a previous IPTc
study and in relation to payments made in other similar situations
in Ghana at the time of the study [4]. Incentives were paid to two
nurses generally working together at each clinic. Two DHMT
supervisors received a monthly salary supplement of US$50.00
and one driver a monthly supplement of US$15.00. These
incentives were equivalent to approximately 14% of the monthly
salary received by DHMT supervisors and 6% of that received by
a government driver.
Table 1. IPTc coverage outcomes by delivery strategy.
IPTc delivery strategies
Community-
based delivery Facility-based delivery
Village
Health
Workers
(VHWs)*
OPD
delivery
(OPD)
EPI outreach
delivery (EPI)
OPD+EPI
delivery
(OPD+EPI)*
Children enrolled in the study (%) 472 (100%) 248 (100%) 244 (100%) 492 (100%)
Children who received the first supervised dose of all 4 courses (‘‘fully covered’’) 326 (69.1%) 171 (69.0%) 151 (61.9%) 322 (65.4%)
Children who received the first supervised dose of 3 courses (‘‘acceptably covered’’) 116 (24.6%) 57 (23.0%) 58 (23.8%) 115 (23.4%)
Children who received the first supervised dose of 2 courses 25 (5.3%) 16 (6.4%) 27 (11.0%) 43 (8.7%)
Children who received the first supervised dose of 1 course 5 (1.0%) 4 (1.6%) 8 (3.3%) 12 (2.5%)
Children who did not receive the first supervised dose of any course 0 (0.0%) 0 (0.0%) 0 (0.0%) 0 (0.0%)
*These figures are slightly different from those published in the effectiveness paper [5] following recalculations.
doi:10.1371/journal.pone.0024871.t001
Table 2. IPTc coverage and adherence outcomes achieved for each course by delivery strategy.
Coverage, % of children who received
at least the first dose* of each course
Adherence, % of children visited each
month who took all 3 doses* [6]
Full adherence and coverage, % of
children covered who took all 3 doses*
Community-based
delivery (VHWs)
Facility-based
delivery (OPD+EPI)
Community-based
delivery (VHWs)
Facility-based
delivery (OPD+EPI)
Community-based
delivery (VHWs)
Facility-based
delivery (OPD+EPI)
June (course 1) 100.0% 100.0% 92.3% 88.2% 92.3% 88.2%
July (course 2) 98.9% 97.5% 88.9% 86.9% 87.9% 84.8%
September
(course 3)
93.6% 88.8% 84.9% 95.6% 79.5% 84.9%
October
(course 4)
69.1% 65.4% 100.0% 97.5% 69.1% 63.8%
*A dose refers to the drugs taken each day of the 3-day IPTc drug regimen; dose 1 given on day 1 was supervised by nurses or VHWs and doses on day 2 and day 3 were
the responsibility of parents/care-takers.
doi:10.1371/journal.pone.0024871.t002
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were calculated using trainees’ bus fare receipts. Transport costs
for delivering IPTc to the distribution points and for conducting
supervision were calculated using data on kilometres travelled, fuel
consumption, fuel cost and vehicle maintenance costs collected
from the project’s vehicle logbook. Transport capital costs were
calculated by dividing the vehicle replacement value at the time of
the study by its useful life, estimated at 7.5 years, apportioned on
the time that it was used for each activity under each delivery
strategy. Communications costs were attributed equally between
the different delivery strategies.
Economic costs represent the opportunity cost, or value of all
resources used irrespective of whether these involve an additional
direct cost. In this study, examples included the time spent by
DHMT staff and nurses who already received a salary but who
spent time on IPTc rather than on their usual duties and the time
spent by VHWs who could otherwise have undertaken paid
activities. Parents/care takers of children in the facility-based arms
of the trial could pick-up their children’s monthly IPT course
during two pre-scheduled week days at their health centre’s OPD
or during the one day EPI outreach clinic. Based on the principal
investigator’s field experience and observations made during the
trial, OPD and EPI nurses were estimated to spend 20% of their
work day on IPTc. VHWs dispensed IPTc drugs at a central point
in the village on three IPTc days and IPTc was assumed to be their
only activity on these days. The time spent by nurses during
training and when dispensing IPTc was valued using a senior
midwife’s gross salary including government allowances [7] (data
obtained from the Ministry of Health’s 2006 payroll records). The
time spent by VHWs on IPTc-related work was valued using the
2005 minimum subsistence monthly wage in Ghana, inflated by
10% to reflect a plausible annual increase in 2006 (US$1.85) based
on previous years’ increases. The time spent by DHMT staff
preparing and conducting training (a total of 2 days), distributing
IPTc to the dispensing sites and for supervision was valued on the
basis of a senior nurse’s salary (including government allowances).
The time spent by a driver delivering IPTc drugs and for
supervision was valued on the basis of a government driver’s salary
(including government allowances).
Overheads, such as resources consumed for storing IPTc drugs
(e.g. building, utilities) were not collected during the study. Costing
of overhead resources used data available from a separate IPTc
study conducted the same year in a neighbouring district, which
had identified the rental value per square meter of hospital space
used by the IPTc intervention to represent the opportunity cost of
using that space [4]. Overhead costs were assumed for the study
population over the six months of the intervention. Specifically,
the value of overhead resources used was assigned on the
assumption that the OPD delivery strategy used 8 square meters
of storage space whilst the EPI based delivery strategy was
assumed to use 80% of this space (because of the shorter storage
period taking place at the facility under this delivery strategy). As
for the community-based delivery strategy, it was estimated to use
half the value of the storage resources used in the OPD delivery
because IPTc drugs were stored in the homes of the VHWs and it
was assumed that the opportunity cost of such space was lower
than that at the health facility.
Finally, the vehicle capital cost was annualised using a discount
rate of 3%. All costs were converted to US$ 2008 using an average
exchange rate of US$1.00=GHC9,781 (http://www.oanda.com/
currency/average).
A sensitivity analysis was conducted on resources whose
valuation was uncertain and likely to affect the cost differential
between delivery strategies focusing on IPTc drug costs, discount
rate for capital costs, share of time spent by nurses and VHWs on
IPTc, amount of incentives received by VHWs and nurses, and
training intensity.
Results
Total costs of IPTc delivery
Table 3 shows the total financial and economic costs of
delivering IPTc through either VHWs or a health facility-based
strategy. The total costs of IPTc delivered through OPD or EPI
clinics are presented separately in Table 4.
IPTc was financially and economically less costly when
dispensed by VHWs than by OPD or EPI nurses. The main
financial cost drivers under the community-based delivery strategy
were resources for delivering drugs to the dispensing sites (28%)
and for supervision (28%) (Table 3). In comparison, under the
facility-based strategy, these resources represented 18% and 26%
of the total financial cost respectively (Table 3). These differences
reflected the more remote location of villages that received IPTc
through VHWs compared to those where treatment was delivered
through health facilities; 190 kilometres were travelled each month
to distribute drugs and conduct supervision under the VHW
delivery strategy compared to 137 kilometres under the facility-
based delivery approach. The main financial cost drivers under
the facility-based delivery were resources for dispensing IPTc to
parents/care takers (39%), reflecting the US$10.00 monthly
incentive paid to 12 nurses working at OPD and EPI clinics
compared to six VHWs dispensing IPTc in the community.
The main economic cost driver when IPTc was dispensed by
VHWs was supervision, accounting for 32% of the total
economic cost (Table 3). In comparison, when drugs were
dispensed by facility-based nurses, supervision resources were
responsible for 27% of the total economic cost (Table 3). This
difference did not reflect more intense supervision of VHWs
compared to nurses because supervisors spent around 40 minutes
at each dispensing site per month. Instead, it was associated with
longer distances travelled and, therefore, time spent by supervi-
sors visiting VHWs compared to OPD and EPI nurses. Similarly,
the relative importance of supervision costs was slightly higher
when IPTc was dispensed by EPI rather than by OPD nurses
(Table 4), reflecting the ‘‘outreach’’ nature of EPI dispensing sites.
When IPTc was provided by facility-based nurses, the main
economic cost driver was resources used for dispensing drugs
(41%) (Table 3). This was higher than under the VHWs delivery
strategy (26%) (Table 3). This reflected the time spent by the 12
nurses involved in dispensing IPTc (one-fifth of their working day
during their respective IPTc days) that was valued using the gross
monthly earning of a senior midwife amounting to US$367.00
per month whilst the time spent by six VHWs (three full days) was
valued on the basis of a minimum monthly subsistence wage of
US$34.00.
Unit economic costs of IPTc
Table 5 shows the numbers and proportions of children fully
covered, acceptably covered, fully covered and fully adherent, and
acceptably covered and fully adherent under the different delivery
strategies, and the corresponding unit economic cost per child.
Detailed unit economic costs per child fully covered are presented
in Table 6. The economic cost per child ‘‘fully covered’’ was
US$4.58 when IPTc was delivered by VHWs and US$5.27 when
delivered by nurses, resulting in an incremental saving of US$0.69
(Table 6). This difference in unit cost reflects lower total economic
costs and higher coverage rates achieved under the community-
based delivery strategy compared to the facility-based approach.
Effectiveness and Costs of IPTc Delivery Systems
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Delivery strategies Community-based delivery (VHWs) Facility-based delivery (EPI+OPD)
Number of children
enrolled 472 492
Costs
Total
Financial
(US$)
Cost
Profile
(%)
Total
Economic
(US$)
Cost
Profile
(%)
Total
Financial
(US$)
Cost
Profile
(%)
Total
Economic
(US$)
Cost
Profile
(%)
IPTc drugs 96 9% 96 6% 100 8% 100 6%
Training
NPersonnel 66 6% 146 10% 66 5% 154 9%
NTransport 13 1% 13 1% 10 1% 10 1%
Delivering drugs to distribution points
NPersonnel 15 1% 67 4% 30 3% 74 4%
NTransport 288 27% 264 18% 180 15% 166 10%
Dispensing IPTc to parents/care-takers
NPersonnel 240 23% 364 24% 480 39% 649 38%
NTransport 0 0% 0 0% 0 0% 0 0%
NOverheads 0 0% 29 2% 0 0% 53 3%
Supervision of IPTc dispensing
NPersonnel 80 8% 272 18% 91 7% 227 14%
NTransport 241 20% 202 14% 233 19% 221 13%
Communications 41 4% 41 3% 40 3% 41 2%
Total 1,053 100% 1,494 100% 1,230 100% 1,696 100%
doi:10.1371/journal.pone.0024871.t003
Table 4. IPTc total financial and economic costs comparing OPD and EPI delivery strategies.
Delivery strategies OPD delivery EPI outreach delivery
Number of children
enrolled 248 244
Costs
Total
Financial
(US$)
Cost
Profile
(%)
Total
Economic
(US$)
Cost
Profile
(%)
Total
Financial
(US$)
Cost
Profile
(%)
Total
Economic
(US$)
Cost
Profile
(%)
IPTc drugs 50 8% 50 6% 50 8% 50 6%
Training
NPersonnel 33 6% 78 9% 33 5% 78 9%
NTransport 5 1% 5 1% 5 1% 5 1%
Delivering drugs to distribution points
NPersonnel 15 3% 37 5% 15 2% 37 4%
NTransport 90 15% 83 10% 90 14% 83 10%
Dispensing IPTc to parents/care-takers
NPersonnel 240 40% 324 38% 240 38% 324 38%
NTransport 0 0% 0 0% 0 0% 0 0%
NOverheads 0 0% 30 3% 0 0% 23 3%
Supervision of IPTc dispensing
NPersonnel 40 7% 117 14% 51 8% 110 13%
NTransport 105 17% 99 12% 128 20% 123 14%
Communications 20 3% 20 2% 20 4% 20 2%
Total 600 100% 843 100% 634 100% 853 100%
doi:10.1371/journal.pone.0024871.t004
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incremental saving when compared with the EPI outreach strategy
(US$1.07 per child covered) (Table 6). For children who were
‘‘fully adherent’’, VHW delivery was both more effective and less
costly than the facility-based strategy: greater proportions of
children took all three doses of four courses or all three doses of at
least three courses using the community-based delivery strategy
(Table 5), with incremental savings of US$0.95 per child ‘‘fully
covered and fully adherent’’ and US$0.54 per child ‘‘acceptably
covered and fully adherent’’.
Sensitivity Analysis
A series of univariate sensitivity analyses were conducted to test
the impact of varying the costs of uncertain resources on IPTc
unit economic costs. The sensitivity analyses aimed to provide a
more realistic picture of IPTc economic outcomes outside the
well supported and funded context of a trial. Results are
presented in Table 7. IPTc dispensed by VHWs remained the
least costly strategy under all scenarios, expect two. When the
monthly incentives paid to VHWs were lowered from US$10.00
to US$5.00 and set to zero for nurses, it became less costly to
deliver IPTc through the facility-based strategy, with a unit
economic cost differential ranging across effectiveness outcomes
between US$0.28 to US$0.80. When VHWs were trained for 5
days whilst nurses were assumed to receive IPTc training through
the routine government curriculum, the unit cost differential
ranged between US$1.37 toUS$2.58 in favour of the facility-
based strategy.
Discussion
The economic outcomes of this study are in agreement with the
findings of a larger trial that investigated the cost-effectiveness of
delivering IPTc (using SP+AQ) through the alternative strategies
of VHWs and RCH trekking teams in The Gambia: VHWs
proved to be a more cost-effective delivery strategy than the
routine public health services. However, in Jasikan, the unit costs
of delivering at least the first dose of all courses (US$4.58 when
delivered by VHWs, US$4.93 by OPD nurses and US$5.65 by
EPI nurses) were higher than in the Gambian study, during which
the cost of delivering the first dose of all three courses was US$1.63
per child when dispensed by VHWs and US$3.47 when dispensed
by RCH trekking teams [6]. However, in The Gambia, the
intermittent treatment regimen was different than in our study as it
included three courses of IPT compared to four, which brought
down coverage cost. In addition, these cost differentials highlight
the importance of the scale of IPTc delivery. With over 12,000
children enrolled, the Gambian trial benefited from economies of
scale as fixed and semi fixed costs (training, incentives, and
supervision) were spread over a larger number of children than in
the Jasikan intervention, which included less than 1,000 children.
OPD and EPI delivery strategies led to lower coverage rates and
therefore higher unit costs compared to delivery by VHWs,
perhaps due in part to the fact that parents/care takers could
collect their drugs over a two-day period at OPD and on only one
day at EPI clinics compared to the three days on which drugs were
available from VHWs.
Table 5. IPTc unit economic costs for different outcome measures by delivery strategy.
Number of children (%) Economic unit cost per child (US$)
Community-based
delivery (VHWs)
Facility- based
delivery
(OPD+EPI)
OPD
delivery
(OPD)
EPI
outreach
delivery
(EPI)
Community-based
delivery (VHWs)
Facility- based
delivery
(OPD+EPI)
OPD
delivery
(OPD)
EPI
outreach
delivery
(EPI)
Children enrolled 472 (100%) 492 (100%) 248 (100%) 244 (100%) $3.17 $3.45 $3.40 $3.50
Children who
received the first
supervised dose
of 4 courses
(children ‘‘fully’’
covered)
326 (69.1%) 322 (65.4%) 171 (69.0%) 151 (61.9%) $4.58 $5.27 $4.93 $5.65
Children who
received the first
supervised dose
of at least 3 courses
(children
‘‘acceptably
covered’’)
442 (93.6%) 437 (88.9%) 228 (93.4%) 209 (84.3%) $3.38 $3.88 $3.70 $4.08
Children who took
all 3 doses of 4
courses (children
‘‘fully covered and
fully adherent’’)
210 (44.6%) 199 (40.5%) n/a n/a $7.56 $8.51 n/a n/a
Children who took
all 3 doses of at
least 3 courses
(children
‘‘acceptably
covered and
fully adherent’’)
305 (64.5%) 312 (63.5%) n/a n/a $4.90 $5.44 n/a n/a
n/a=data not available.
doi:10.1371/journal.pone.0024871.t005
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spent by nurses on IPTc and the impact that this had on their
routine tasks. In the selected OPDs, the workload of the nursing
staff was manageable, so that no major impact on the quality of
routine services was expected. At EPI outreach clinics, each nurse
was estimated to serve annually an average of 1104 children aged
between 0 to 4 years, equivalent to 92 children at each monthly
clinic. Adding IPTc to their routine task inevitably increased
nurses’ workload and could lead to potential fatigue and, in the
long-run, to negative effects on the overall quality of EPI services
and IPTc. However, it is also important to consider that IPTc
dispensed by health care professionals may create opportunities for
children, such as the diagnosis of other diseases. Some of these
issues have been explored in relation to IPTi delivery [9,10] and
are currently being debated in relation to the use of IPT in
pregnant women. In the Gambia, four additional people were
needed to support the delivery of IPTc by RCH trekking teams.
Additional health personnel may, therefore, be required if IPTc is
introduced as a malaria control intervention delivered through
routine health services, notably those provided on an intermittent
basis such as EPI and RCH programmes.
Whilst the EPI delivery strategy may have reached children from
more remote areas than could be reached through OPD, EPI
coverage in Jasikan is high and relatively equitable [11]. There are,
therefore, additional uncertainties regarding the effectiveness of
delivering IPTc through the EPI route in settings where EPI
coverage is lower and/or inequitable, such as in several other
countries of West Africa with seasonal malaria transmission. More
generally, in many low income countries, public health services are
disproportionately used by wealthier populations, who may be at
lowerriskofmalariaand,ifexpectedtoliveinmoreaccessibleareas,
may benefit from other malaria control interventions. Community-
based delivery strategies for ITNs have been reported to achieve
higher coverage in lower socio-economic households than health
facility-based alternatives [12] and such focussed delivery during a
fixed time-period fits well with the delivery requirements of IPTc in
areas with seasonal transmission of malaria.
Overall, impressive adherence rates were achieved with all three
delivery strategies, although with higher rates achieved by VHWs
than by facility-based nurses. IPT drugs were administered to
children in sugared water and this approach may partly explain the
high adherence levels achieved during this trial. Higher coverage and
adherence achieved using the VHW strategy may have reflected
preferences for patients/care givers to visit a member of their
community that they know rather than a facility-based health worker.
Visiting the former may also be more convenient as they can
theoreticallybe visited at any time of the day as opposed to the limited
opening hours of OPDs and EPI clinics.Parents/care-takersmay also
prefer services they can access locally and for which limited travel is
required, as they commonly do when seeking fever malaria treatment
from local drug shops [13,14,15,16,17,18,19]. Combining IPTc
delivery with other malaria interventions, such as diagnosis using
rapid test kits and treatment with artemisinin combination therapy,
could be explored to decrease implementation costs. To ensure that
they gave the right drug in the right dosage at the right time, VHWs
would need support, notably in terms of training and supervision. In
Table 6. IPTc economic costs per child receiving the first supervised dose of all four courses by delivery strategy.
Delivery strategies
Community-based
delivery (VHWs)
Facility- based
delivery (OPD+EPI) OPD delivery (OPD) EPI outreach delivery (EPI)
Number of children who received at
least the first dose of all 4 courses 326 322 171 151
Costs
Unit Cost
(US$)
Cost
Profile (%)
Unit Cost
(US$)
Cost
Profile (%)
Unit Cost
(US$)
Cost
Profile (%)
Unit Cost
(US$)
Cost
Profile (%)
IPTc Drugs 0.29 6% 0.31 6% 0.29 6% 0.33 6%
Training
NPersonnel 0.45 10% 0.48 9% 0.45 9% 0.51 9%
NTransport 0.04 1% 0.03 1% 0.03 1% 0.04 1%
Delivering drugs to distribution points
NPersonnel 0.20 4% 0.23 4% 0.22 4% 0.25 4%
NTransport 0.81 18% 0.51 10% 0.48 10% 0.55 10%
Dispensing IPTc to parents/care-takers
NPersonnel 1.12 24% 2.02 38% 1.90 39% 2.15 38%
NTransport 0.00 0% 0.00 0% 0.00 0% 0.00 0%
NOverheads 0.09 2% 0.16 3% 0.17 4% 0.15 3%
Supervision of IPTc dispensing
NPersonnel 0.83 18% 0.70 14% 0.68 13% 0.73 13%
NTransport 0.62 14% 0.69 13% 0.58 12% 0.81 14%
Communications 0.13 3% 0.13 2% 0.12 2% 0.14 2%
Total Unit Cost: 4.58 100% 5.27 100% 4.93 100% 5.65 100%
Incremental Saving (VHWs vs. FB) 0.69
Incremental Saving (VHWs vs. OPD) 0.35
Incremental Saving (VHWs vs. EPI) 1.07
Incremental Saving (EPI vs.OPD) 20.72
doi:10.1371/journal.pone.0024871.t006
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PLoS ONE | www.plosone.org 7 November 2011 | Volume 6 | Issue 11 | e24871Jasikan, the trial benefited from good supervision from the DHMT,
with monthly incentives of US$50.00 given to IPTc supervisors. In
comparison, in The Gambia, supervisors did not receive any salary
supplement. Instead, considerable efforts were made to support
dispensers through job aids such as coloured cards. In addition,
similar strategies could well be developed for parents/care takers.
Finally, in Jasikan, dispensers received a monthly incentive of $10.00,
which was similar to that received by VHWs in the neighbouring
district of Hohoe but higher than the incentives given everyquarter to
VHWs involved in home based management of malaria [20,21,22]
or in newborn care interventions [23]. Careful examinations of
strategies and costs of strategies for sustaining networks of
community-based volunteers need to be conducted. In conclusion,
this study has shown that whilst high levels of coverage with IPTc can
be achieved in a rural area of Ghana using delivery by VHWs or
nurses working at OPDs or EPI outreach clinics, delivery by VHWs
was less costly and had other non-monetary benefits.
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Table 7. Sensitivity analyses on IPTc economic unit costs (US$) for different coverage and adherence outcomes comparing
community- and facility-based delivery strategies.
Variable Variation tested Unit economic cost (US$)
Rationale
for variation
tested
Child fully
covered
Child acceptably
covered
Child fully
adherent &
fully covered
Child fully
adherent &
acceptably
covered
VHWs* FB* VHWs* FB VHWs* FB VHWs* FB
Base case - 4.58 5.27 3.38 3.88 7.56 8.51 4.90 5.44 -
Drug costs +25% 4.66 5.35 3.44 3.94 7.79 8.64 4.98 5.52 Uncertainty
regarding cost
of drugs in the
future [24].
225% 4.51 5.19 3.33 3.82 7.33 8.38 4.82 5.36
Discount rate Increase from
3% to 5%
4.56 5.26 3.36 3.87 7.52 8.49 4.87 5.43 Alternative rate
used in economic
costing studies.
Share of time
spent on IPTc
Nurses time
increase from
20% to 30%
4.58 5.53 3.38 4.08 7.56 8.93 4.90 5.71 No evidence
available on exact
share of time
dispensers spend
on IPT activities in
relation to their
other tasks.
VHWs time
decrease from
100% to 50%
4.39 5.27 3.24 3.88 7.26 8.51 4.70 5.44
Incentives Decrease from
US$10.00 to
US$5.00 for
VHWs and set
to zero
for nurses
4.09 3.72 3.02 2.74 6.80 6.00 4.37 3.84 In Ghana,
community-based
volunteers received
US$8.00 quarterly
(US$2.00 per
month in addition
to non-monetary
benefits (raincoats,
bicycles, etc) [22],
or US$5.00 [23]
Training
intensity
Increase from 1
day to 5 days
for VHWs; nurses
assumed to be
trained on IPTc
during routine
government
curriculum
6.45 4.59 4.75 3.38 10.00 7.41 6.89 4.74 In The Gambia,
community-based
volunteers were
trained on IPTc
for 5 days [6].
*VHWs=Village Health Workers; FB=Facility-Based delivery (OPD+EPI nurses).
doi:10.1371/journal.pone.0024871.t007
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